drugset / Trial / NCT01676987

Evaluation of the Efficacy and Safety of a Fixed-dose, Single-capsule Budesonide-formoterol Combination in Uncontrolled Asthma

NCT01676987 ↗

Phase 3 Completed 181 enrolled Ache Laboratorios Farmaceuticos S.A.
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the efficacy and safety of a fixed-dose, single-capsule budesonide(400µg)-formoterol(12µg) combination, in comparison with budesonide alone, both delivered via a dry powder inhaler, in 181 patients with uncontrolled asthma.This was Randomized, double-blind, multicenter, phase III, parallel clinical trial.

Timeline

Start
2009-04
Primary completion
2010-09
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule 400 ug Inhaled
Subject Formoterol Other / unclassified 12 ug Inhaled

Indications